US18507C1036 - Common Stock
CLEARPOINT NEURO INC
NASDAQ:CLPT (5/3/2024, 7:00:00 PM)
After market: 5.94 +0.07 (+1.19%)5.87
+0.35 (+6.34%)
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 108 full-time employees. The company went IPO on 2019-07-03. The firm develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system is an integrated system comprised of hardware components, disposable components and intuitive, menu-driven software. Its hardware components consist primarily of a head fixation frame, computer workstation, and in-room monitor. Its disposable components for its ClearPoint system consist primarily of its SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Cannula. Its ClearPoint system software guides the physician in surgical planning, device alignment, navigation to the target and procedure monitoring. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance.
CLEARPOINT NEURO INC
120 S. Sierra Avenue, Suite 100
Solana Beach CALIFORNIA 92618
P: 19499006833
CEO: Joseph M. Burnett
Employees: 108
Website: https://www.clearpointneuro.com/
These penny stocks offer robust operational opportunities amid wider economic and market concerns pushing weaker companies downward.
Les centres ASPIRE-FTD dans l’UE et aux États-Unis utiliseront la navigation ClearPoint® avec la canule SmartFlow® pour l’administration de thérapie...
Prüfzentren für ASPIRE-FTD in der EU und den USA verwenden ClearPoint® Navigation zusammen mit der SmartFlow®-Kanüle für die intrathalamische Gentherapie...
I siti ASPIRE-FTD nell’UE e negli Stati Uniti utilizzeranno la navigazione ClearPoint® insieme alla cannula SmartFlow® per la somministrazione della...
Los centros ASPIRE-FTD de la UE y EE. UU. ...
De onderzoekscentra van ASPIRE-FTD in de EU en de VS zullen gebruikmaken van ClearPoint® Navigation in combinatie met de SmartFlow® Cannula voor de...
Here you can normally see the latest stock twits on CLPT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: